Zimmer Biomet Holdings Inc (ZBH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Zimmer Biomet Holdings Inc (ZBH) reports robust Q4 performance with nearly 5% constant currency revenue growth and outlines strategic plans for future innovation and market expansion.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is $2.31, expectations were $2.3. Operator: Good morning, ladies and gentlemen,
RBC Capital Sticks to Its Buy Rating for Zimmer Biomet Holdings (ZBH)
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report) yesterday and set a price
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors
Shares of Zimmer Biomet Holdings Inc. ZBH slipped 5.14% to $102.69 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to 6,083.57 and the Dow Jones Industrial Average DJIA falling 0.28% to 44,747.63.
Zimmer Biomet (ZBH) Surpasses Q4 Earnings and Revenue Estimates
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.31 per share, beating the Zacks Consensus Estimate of $2.30 per share. This compares to earnings of $2.20 per share a year ago. These figures are adjusted for non-recurring items.
Truist Financial Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2024 Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, February 06,
Earnings call transcript: Zimmer Biomet Q4 2024 sees strong sales growth
Inc. reported robust financial results for the fourth quarter of 2024, surpassing analysts' expectations with an earnings per share (EPS) of $2.31, slightly above the forecast of $2.30. The company's revenue reached $2.
Zimmer Biomet Holdings Inc. Q4 Profit Decreases, But Beats Estimates
Zimmer Biomet Holdings Inc. (ZBH) announced a profit for fourth quarter that decreased from the same period last year but beat the
Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zimmer Biomet (ZBH) reported $2.02 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 4.3%. EPS of $2.31 for the same period compares to $2.20 a year ago.
ZBH's Q4 Earnings Beat, Margins Contract, Stock Down in Premarket
Zimmer Biomet benefits from its diversified portfolio outside of core orthopedics and the company's strategic investments in ...
Zimmer Biomet: Adding To The Growth Profile
Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...
Why Is Zimmer Biomet Stock Trading Lower On Thursday?
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the ...
Zimmer Biomet forecasts 2025 profit below estimates
Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it ...